We found that adipocyte-specific CD1d deletion abrogated NKT cell activation via adipocytes and thus ameliorated inflammation in adipose tissue, resulting in reduced obesity and improved insulin sensitivity. The gene discussed is CD1D; the disease is obesity disorder.